We are live on ! Find out more
OM icon

Outset Medical
OM

73 hedge funds and large institutions have $23.4M invested in Outset Medical in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more call options, than puts

Call options by funds: $159K | Put options by funds: $73K

33% more capital invested

Capital invested by funds: $17.6M → $23.4M (+$5.75M)

0.66% less ownership

Funds ownership: 3.33% → 2.67% (-0.66%)

6% less funds holding

Funds holding: 78 → 73 (-5)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
16
Reduced
24
Closed
16
Calls
$159K
Puts
$73K
Net Calls
+$86K
Net Calls Change
+$85K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$526K
2
BC
Birchview Capital
Vermont
+$299K
3
Morgan Stanley
Morgan Stanley
New York
+$210K
4
Squarepoint
Squarepoint
New York
+$130K
5
Two Sigma Investments
Two Sigma Investments
New York
+$108K

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$1.23M
2
MIC
Mubadala Investment Company
United Arab Emirates
-$975K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$917K
4
Millennium Management
Millennium Management
New York
-$412K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.08M -$917K -73,504 -23%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.9M -$29.6K -2,375 -1%
GC
3
GMT Capital
Georgia
$1.63M – – –
Morgan Stanley
4
Morgan Stanley
New York
$1.59M +$210K +16,800 +21%
Millennium Management
5
Millennium Management
New York
$1.55M -$412K -33,012 -26%
Ensign Peak Advisors
6
Ensign Peak Advisors
Utah
$1.43M -$81.4K -6,519 -7%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$1.11M -$247K -19,776 -23%
CWG
8
C WorldWide Group
Denmark
$1.11M – – –
GCP
9
GSA Capital Partners
United Kingdom
$1.06M -$127K -10,144 -14%
BlackRock
10
BlackRock
New York
$1.04M +$22.9K +1,838 +3%
Renaissance Technologies
11
Renaissance Technologies
New York
$762K +$526K +42,171 +1,168%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$626K -$4.33K -347 -0.9%
Two Sigma Investments
13
Two Sigma Investments
New York
$542K +$108K +8,622 +36%
Deutsche Bank
14
Deutsche Bank
Germany
$463K – – –
Two Sigma Advisers
15
Two Sigma Advisers
New York
$458K +$6.33K +507 +2%
BC
16
Birchview Capital
Vermont
$409K +$299K +23,917 +3,586%
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$322K -$89.7K -7,189 -27%
State Street
18
State Street
Massachusetts
$211K -$3.91K -313 -2%
Tudor Investment Corp
19
Tudor Investment Corp
Connecticut
$200K – – –
Squarepoint
20
Squarepoint
New York
$174K +$130K +10,452 New
Jane Street
21
Jane Street
New York
$121K -$49.6K -3,972 -35%
Group One Trading
22
Group One Trading
Illinois
$114K +$16.1K +1,286 +23%
BCM
23
Bridgeway Capital Management
Texas
$111K – – –
Northern Trust
24
Northern Trust
Illinois
$110K – – –
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$103K +$54.5K +4,364 +238%
1
2 3 4

OM Hedge Fund Activity: Q4 2024 in Review

73 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2024, worth a combined $23.4M — up 33% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of OM and 12 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 16 added.

The largest buyer was Renaissance Technologies, adding an estimated $526K. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.

  • 73 institutional investors held Outset Medical (OM) as of Q4 2024, down from 78 in Q3 2024.
  • Funds reported $23.4M of Outset Medical stock for Q4 2024, up 33% quarter-over-quarter.
  • 12 funds opened new Outset Medical positions in Q4 2024 and 16 closed out, a net change of -4 holders.
  • The largest Outset Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $526K added.
  • The largest Outset Medical seller in Q4 2024 was Ameriprise, an estimated $1.23M sold.

Based on aggregated 13F filings for Q4 2024.